Search results
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 2 days agoMedicare spending on the drugs has also spiked in recent years. The drug’s Danish manufacturer, Novo...
TONI SAYS: Enrolling in Medicare when laid-off
Odessa American· 1 day agoSteve is 68, enrolled in Medicare Part A but never enrolled in Medicare B because he had employer benefits. Please explain what our Medicare< ...
CVS Plummets as Rising Medical Costs Hit Profit Forecast
Bloomberg via Yahoo Finance· 1 day ago...tumbled the most in nine years after the company cut its annual earnings outlook for the second...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
San Francisco Chronicle· 1 day agoCVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below...
Medicare Warnings Stop Nursing Homes From Overusing Antipsychotic Meds
US News & World Report· 6 days agoWarning letters sent by Medicare officials can prompt a decline in antipsychotic prescriptions for seniors with dementia, a new study finds. Letters sent ...
Use of antipsychotic meds for older adults drops after warning letter from Medicare
UPI· 6 days agoWarning letters sent by Medicare officials can prompt a decline in antipsychotic prescriptions for...
J&J, Bristol Myers lose challenges to US drug price negotiation program By Reuters
Investing.com· 3 days agoDistrict Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge to uphold the...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 5 hours agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters· 3 days ago, opens new tab to a law requiring them to negotiate the prices of their blockbuster blood clot...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
Associated Press Finance via Yahoo Finance· 1 day agoCVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below...